Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.965 USD | -7.75% | +5.88% | -33.78% |
Mar. 25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
Mar. 25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.